<?xml version="1.0" encoding="UTF-8"?>
<p>As new COVID-19 diagnostic technologies are introduced, studies aimed at validating their usefulness in clinical settings will be of crucial importance (
 <xref rid="B26" ref-type="bibr">26</xref>). In this sense, collaborative data sharing on SARS-CoV-2 diagnostic performance evaluation, such as the initiatives led by FIND (
 <xref rid="B24" ref-type="bibr">24</xref>) and the WHO, will contribute to rapid adoption of new diagnostic technology and will inform public health decisions on a global scale.
</p>
